Details for New Drug Application (NDA): 209937
✉ Email this page to a colleague
NDA 209937 describes SODIUM TETRADECYL SULFATE, which is a drug marketed by Hikma and is included in one NDA. It is available from one supplier. Additional details are available on the SODIUM TETRADECYL SULFATE profile page.
The generic ingredient in SODIUM TETRADECYL SULFATE is sodium tetradecyl sulfate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.
The generic ingredient in SODIUM TETRADECYL SULFATE is sodium tetradecyl sulfate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.
Summary for 209937
| Tradename: | SODIUM TETRADECYL SULFATE |
| Applicant: | Hikma |
| Ingredient: | sodium tetradecyl sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 209937
Suppliers and Packaging for NDA: 209937
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SODIUM TETRADECYL SULFATE | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 209937 | ANDA | Hikma Pharmaceuticals USA Inc. | 24201-201 | 24201-201-05 | 5 VIAL, GLASS in 1 CARTON (24201-201-05) / 2 mL in 1 VIAL, GLASS (24201-201-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 60MG/2ML (30MG/ML) | ||||
| Approval Date: | Dec 9, 2019 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
